Increased Risk of Testicular Germ Cell Cancer Among Infertile Men
Top Cited Papers
Open Access
- 23 February 2009
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 169 (4) , 351-356
- https://doi.org/10.1001/archinternmed.2008.562
Abstract
Testicular germ cell cancer is the most common cancer among young men in industrialized countries. During the last 3 to 5 decades, there has been a notable and continued increase in the incidence of testicular germ cell cancers in men. Among US men, incidence has increased from 3.8 to 6.8 cases per 100 000 person-years in whites from 1975 to 2002.1 More profound increases have been seen in Scandinavian countries such as Norway, where incidence has increased from 3.5 to 10 cases per 100 000 person-years from 1960 to 2000.2 During the same period, there is evidence of a decline in semen quality and fertility in industrialized nations.3,4 However, it is unclear whether these 2 trends are independent or related to one another.Keywords
This publication has 22 references indexed in Scilit:
- Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in DenmarkInternational Journal of Andrology, 2006
- INCREASED INCIDENCE OF TESTICULAR CANCER IN MEN PRESENTING WITH INFERTILITY AND ABNORMAL SEMEN ANALYSISJournal of Urology, 2005
- Subfertility and the risk of testicular germ cell tumors (United States)Cancer Causes & Control, 2005
- Clinical Pattern and Therapeutic Results Achieved in 1490 Patients with Germ-Cell Tumours of the Testis: the Experience of the Spanish Germ-Cell Cancer Group (GG)European Urology, 2002
- Socio‐economic differences in incidence rates of cancers of the male genital organs in Finland, 1971–95International Journal of Cancer, 2002
- Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing overNature Genetics, 1996
- WHO LABORATORY MANUAL FOR THE EXAMINATION OF HUMAN SEMEN AND SPERM‐CERVICAL MUCUS INTERACTIONInternational Journal of Andrology, 1996
- Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancerCell, 1995
- Evidence for decreasing quality of semen during past 50 years.BMJ, 1992
- Testis cancer: Post‐natal hormonal factors, sexual behaviour and fertilityInternational Journal of Cancer, 1989